Priority Date: 02.12.11 (US 201161566273P)

MULTIVALENT ANTIBODY COMPLEXES TARGETING IGF-1R SHOW POTENT TOXICITY AGAINST SOLID TUMORS

  • Application ID: EP12854231
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 2000
Headquarter in Munich
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Kanzlei bohmann is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 02.12.2011 - Priority Date (US 201161566273P)
  • 06.06.2013 - Publication A1 (WO2013082254)
  • 08.10.2014 - Publication A1 (EP2785382)